DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

New Legislation Impacting Your Profession
June 12, 2020

Click here to view a full list of bill summaries from the 2020 Florida Legislative Session that may impact your profession. Continue reading


June Board of Medicine Meeting
May 19, 2020

The Board of Medicine will be conducting the June meeting via teleconference call. Click here to view meeting information. Continue reading




Supporting Documents
Medical Degree Verification
NICA FORM
Postgraduate Training Verification